Form 8.3 - Horizon Therapeutics plc

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Millennium International Management LP
Company dealt in	Horizon Therapeutics plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	IE00BQPVQZ61
Date of dealing	25^th May 2023

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	4,838,015 (2.115%)		-
(2) Derivatives (other than options)	-		-
(3) Options and agreements to purchase/sell	437,200 (0.191%)		1,979,700 (0.865%)
Total	5,275,215 (2.306%)		1,979,700 (0.865%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (USD) (Note 5)
Purchase	43	99.63
Purchase	25	100.00
Sale	3,353	100.00
Purchase	271	99.97
Purchase	131	99.91
Purchase	49	99.89
Purchase	25	99.98
Purchase	175	99.57
Purchase	75	99.55
Sale	200	100.06
Sale	896	100.07
Purchase	137	99.32
Purchase	50	99.50
Sale	125	99.50
Sale	106	100.08
Purchase	110	99.93
Sale	200	100.05
Purchase	20	99.45
Sale	670	100.04
Purchase	100	99.72
Purchase	75	99.59
Sale	512	100.11
Sale	2,416	100.01
Sale	200	100.02
Sale	88	100.10
Purchase	50	99.54
Purchase	125	99.88
Sale	204	100.03
Purchase	107	99.64
Purchase	2	99.39
Purchase	129	99.52
Purchase	677	99.92
Purchase	19	99.99
Purchase	18	100.00
Purchase	3	99.97
Purchase	1	99.89
Purchase	1	99.87
Purchase	197	99.51
Purchase	3	99.94
Purchase	13	99.96
Purchase	141	99.49
Purchase	1	99.29
Purchase	72	99.54
Purchase	1	99.88
Sale	4,869	99.88
Purchase	9	99.84
Purchase	119	99.30
Purchase	5	99.34
Sale	3,500	99.35
Sale	270	99.39
Sale	359	99.60
Purchase	4,881	99.52
Sale	1,013	99.92
Purchase	5,000	100.00
Sale	1	100.00
Sale	399	99.97
Sale	5	99.95
Purchase	190	99.91
Sale	127	99.91
Sale	174	99.89
Sale	103	99.98
Purchase	10,000	99.51
Sale	4	99.51
Purchase	5,119	99.55
Sale	402	99.56
Sale	29	100.06
Sale	2,225	99.32
Sale	478	99.94
Purchase	14	99.48
Purchase	973	99.50
Sale	944	99.50
Sale	25	100.08
Sale	123	99.93
Purchase	80	99.37
Sale	85	100.05
Purchase	550	99.45
Sale	114	100.04
Purchase	2,097	99.96
Sale	5	99.96
Sale	12	99.72
Sale	6	99.46
Sale	58	100.11
Sale	100	99.36
Sale	10	99.79
Sale	87	99.67
Sale	187	100.02
Sale	952	99.47
Sale	300	99.29
Purchase	383	99.38
Sale	650	99.54
Purchase	755	99.88
Sale	206	99.88
Sale	275	99.31
Sale	400	99.81
Sale	116	99.71
Sale	33	99.61
Sale	90	99.90
Sale	9	99.84
Purchase	300	99.25
Sale	529	99.42
Sale	50	99.27
Sale	13	99.58
Sale	34	100.12
Sale	107	99.64
Sale	3	99.60
Sale	3	99.52
Sale	6	99.92
Sale	2	99.99
Sale	1	100.00
Sale	6	99.98
Sale	3	99.56
Sale	6	99.94
Sale	4	99.80
Sale	3	99.67
Sale	6	99.31
Sale	1	99.90
Sale	6	99.43

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (USD) (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price (USD)	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
Put Option	Purchased	150,000	70.00	American	1/19/2024
Call Option	Purchased	1,000	110.00	American	17/11/2023
Put Option	Purchased	200,000	70.00	American	17/11/2023

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure	26^th May 2023
Contact name	Stephen Glasper
Telephone number	[phone]
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making disclosure:	Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit (USD)	Type e.g. American, European etc.	Expiry date
IE00BQPVQZ61	Put Option	Purchased	300	80.00	American	1/17/2025
IE00BQPVQZ61	Put Option	Purchased	300	90.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	1,200	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	201,200	115.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	50,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	29,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	3,600	105.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	10,900	105.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Written	99,500	115.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300,000	85.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	283,900	100.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300	110.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	53,500	95.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	300	110.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Written	300	110.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Written	400	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	400	110.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	250,000	85.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Purchased	50,000	90.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	50,000	90.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Purchased	50,000	100.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Purchased	125,300	110.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	150,000	100.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Purchased	2,500	110.00	American	17/11/2023
IE00BQPVQZ61	Call Option	Purchased	4,500	110.00	American	10/20/2023
IE00BQPVQZ61	Call Option	Purchased	100,000	100.00	American	12/15/2023
IE00BQPVQZ61	Call Option	Written	100,000	110.00	American	12/15/2023
IE00BQPVQZ61	Put Option	Purchased	100,000	85.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	50,000	101.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	2,800	100.00	American	10/20/2023
IE00BQPVQZ61	Call Option	Purchased	2,800	100.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Written	50,000	85.00	American	15/09/2023
IE00BQPVQZ61	Put Option	Purchased	50,000	85.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Purchased	2,600	90.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Purchased	40,900	100.00	American	17/11/2023
IE00BQPVQZ61	Call Option	Purchased	200	100.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	200	100.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	200,000	70.00	American	17/11/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET

Sequence Number: 1105738

Time of Receipt (offset from UTC): 20230526T124755+0100